{"pageContent": "Introduction: Prostate cancer (PC) most of the time presents with an indolent course. Thus, delays in treatment due to any causes might not affect long-term survival and may not affect cancer cure rates.", "metaData": {"source": "A population-based study of progression to metastatic prostate cancer in Australia\nhttps://pubmed.ncbi.nlm.nih.gov/25983117/"}}